TABLE 4.

Acute myeloid leukemia (AML) results in accordance with WHO 2008.

AML category as per WHO 2008 classification	n (%)
Acute myeloid leukemia with recurrent genetic abnormalities
AML with t(8;21)(q22,q22); RUNX1-RUNX1T1	11 (8.6)
AML with inv(16)(p13,1q22) or t(16;16)(p13.1;q22); CBFB-MYH11	10 (7.8)
AML with t(9;11)(p22;q22); MLL T3-MLL	3 (2.3)
AML with (6;9) (p22;q23)	1 (0.8)
AML with inv(3) (q21q26.2) or t(3;3) (q21;q26.2)	1 (0.8)
Provisional entity: AML with mutated NPM1	4 (3.1)
AML with myelodysplasia-related changes	18 (14.1)
Therapy-related myeloid neoplasms	3 (2.3)
Acute myeloid leukemia, not otherwise specified
Acute erythroid leukemia	1 (0.8)
Acute megakaryoblastic leukemia	1 (0.8)
Acute monoblastic/monocytic leukemia	14 (10.9)
Acute myelomonocytic leukemia	17 (13.3)
Acute panmyelosis with myelofibrosis	–
AML without maturation	27 (21.1)
AML with maturation	10 (7.8)
AML with minimal differentiation	7 (5.5)
Total	128 (100)